Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951. (Q52899418)

9 May 2018

title

Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951. (English)

1 reference

9 May 2018

main subject

lymphoblastic lymphoma

1 reference

Stéphane Ducassou

1

1 reference

9 May 2018

Céline Ferlay

2

1 reference

9 May 2018

Christophe Bergeron

3

1 reference

9 May 2018

Sandrine Girard

4

1 reference

9 May 2018

Geneviève Laureys

5

1 reference

9 May 2018

Hélène Pacquement

6

1 reference

9 May 2018

Dominique Plantaz

7

1 reference

9 May 2018

Patrick Lutz

8

1 reference

9 May 2018

Jean-Pierre Vannier

9

1 reference

9 May 2018

Anna Uyttebroeck

10

1 reference

9 May 2018

Yves Bertrand

11

1 reference

9 May 2018

language of work or name

English

0 references

publication date

7 January 2011

1 reference

9 May 2018

British Journal of Haematology

published in

1 reference

9 May 2018

volume

152

1 reference

9 May 2018

page(s)

441-451

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: a report from the children's oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Precursor B-cell lymphoblastic lymphoma of the ovaries: an immunohistochemical study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Primary cutaneous lymphoblastic lymphoma in children: series of eight cases with review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08541.X

10.1111/J.1365-2141.2010.08541.X

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

21210776

1 reference

9 May 2018